Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Garrido, Marcial Velasco
and
Mangiapane, Sandra
2009.
Surrogate outcomes in health technology assessment: An international comparison.
International Journal of Technology Assessment in Health Care,
Vol. 25,
Issue. 03,
p.
315.
Sansom, Lloyd
2010.
Assessing the Value of Medicines.
Pharmaceutical Medicine,
Vol. 24,
Issue. 2,
p.
89.
Ciani, Oriana
and
Taylor, Rod S
2011.
Treatment effect bias in randomised controlled trials using surrogate outcomes: a preliminary cohort study analysis.
Trials,
Vol. 12,
Issue. S1,
Soto Álvarez, Javier
2012.
Evaluación económica de medicamentos y tecnologías sanitarias:.
p.
171.
Hawkins, Neil
Richardson, Gerry
Sutton, Alex J
Cooper, Nicola J
Griffiths, Chris
Rogers, Anne
and
Bower, Peter
2012.
Surrogates, meta‐analysis and cost‐effectiveness modelling: a combined analytic approach.
Health Economics,
Vol. 21,
Issue. 6,
p.
742.
Ciani, O.
and
Taylor, R. S.
2013.
SURROGATE, FRIEND OR FOE? THE NEED FOR CASE STUDIES OF THE USE OF SURROGATE OUTCOMES IN COST‐EFFECTIVENESS ANALYSES.
Health Economics,
Vol. 22,
Issue. 2,
p.
251.
Oriana, Ciani
Martin, Hoyle
Toby, Pavey
Chris, Cooper
Ruth, Garside
Claudius, Rudin
and
Rod, Taylor
2013.
Complete Cytogenetic Response and Major Molecular Response as Surrogate Outcomes for Overall Survival in First-Line Treatment of Chronic Myelogenous Leukemia: A Case Study for Technology Appraisal on the Basis of Surrogate Outcomes Evidence.
Value in Health,
Vol. 16,
Issue. 6,
p.
1081.
Rocchi, Angela
Khoudigian, Shoghag
Hopkins, Rob
and
Goeree, Ron
2013.
Surrogate outcomes: experiences at the Common Drug Review.
Cost Effectiveness and Resource Allocation,
Vol. 11,
Issue. 1,
p.
31.
Félix, Jorge
Aragão, Filipa
Almeida, João M
Calado, Frederico JM
Ferreira, Diana
Parreira, António BS
Rodrigues, Ricardo
and
Rijo, João FR
2013.
Time-dependent endpoints as predictors of overall survival in multiple myeloma.
BMC Cancer,
Vol. 13,
Issue. 1,
Rathbone, John
Kaltenthaler, Eva
Richards, Anna
Tappenden, Paul
Bessey, Alice
and
Cantrell, Anna
2013.
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS).
BMJ Open,
Vol. 3,
Issue. 11,
p.
e003573.
Ciani, Oriana
Davis, Sarah
Tappenden, Paul
Garside, Ruth
Stein, Ken
Cantrell, Anna
Saad, Everardo D.
Buyse, Marc
and
Taylor, Rod S.
2014.
VALIDATION OF SURROGATE ENDPOINTS IN ADVANCED SOLID TUMORS: SYSTEMATIC REVIEW OF STATISTICAL METHODS, RESULTS, AND IMPLICATIONS FOR POLICY MAKERS.
International Journal of Technology Assessment in Health Care,
Vol. 30,
Issue. 3,
p.
312.
Cressman, Sonya
Browman, George P.
Hoch, Jeffrey S.
Kovacic, Laurel
and
Peacock, Stuart J.
2015.
A Time-Trend Economic Analysis of Cancer Drug Trials.
The Oncologist,
Vol. 20,
Issue. 7,
p.
729.
Woolacott, Nerys
Corbett, Mark
Jones-Diette, Julie
and
Hodgson, Robert
2017.
Methodological challenges for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview.
Journal of Clinical Epidemiology,
Vol. 90,
Issue. ,
p.
108.
Corbett, Mark S.
Webster, Andrew
Hawkins, Robert
and
Woolacott, Nerys
2017.
Innovative regenerative medicines in the EU: a better future in evidence?.
BMC Medicine,
Vol. 15,
Issue. 1,
Hettle, Robert
Corbett, Mark
Hinde, Sebastian
Hodgson, Robert
Jones-Diette, Julie
Woolacott, Nerys
and
Palmer, Stephen
2017.
The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal.
Health Technology Assessment,
Vol. 21,
Issue. 7,
p.
1.
Ciani, Oriana
Buyse, Marc
Drummond, Michael
Rasi, Guido
Saad, Everardo D.
and
Taylor, Rod S.
2017.
Time to Review the Role of Surrogate End Points in Health Policy: State of the Art and the Way Forward.
Value in Health,
Vol. 20,
Issue. 3,
p.
487.
Haslam, Alyson
Hey, Spencer P.
Gill, Jennifer
and
Prasad, Vinay
2019.
A systematic review of trial-level meta-analyses measuring the strength of association between surrogate end-points and overall survival in oncology.
European Journal of Cancer,
Vol. 106,
Issue. ,
p.
196.
Cooper, Katy
Tappenden, Paul
Cantrell, Anna
and
Ennis, Kate
2020.
A systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer.
British Journal of Cancer,
Vol. 123,
Issue. 11,
p.
1686.
Pinto, Ashlyn
Naci, Huseyin
Neez, Emilie
and
Mossialos, Elias
2020.
Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs.
Value in Health,
Vol. 23,
Issue. 3,
p.
319.
Bakopoulou, Athina
2020.
Prospects of Advanced Therapy Medicinal Products–Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.
Journal of Endodontics,
Vol. 46,
Issue. 9,
p.
S175.